CT-Based Radiomics in the Characterization of Solid Renal Tumors: A Systematic Review
Cancers · 27.05.2026 · 18 (11) · 1758
DOI: 10.3390/cancers18111758 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.05.2026. Verfasst von Petros Koumpis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Radiology, University Hospital of Ioannina, University Campus, 45110 Ioannina, Greece. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Renal cell carcinoma (RCC) is a global health challenge characterized by significant histological heterogeneity. Conventional contrast-enhanced CT often struggles to differentiate RCC from solid benign renal tumors like fat-poor angiomyolipoma (fpAML) and renal oncocytoma (RO), leading to potential surgical overtreatment. CT-based radiomics has emerged as a promising non-invasive approach that extracts high-dimensional quantitative imaging features to support lesion characterization and may contribute toward more comprehensive, biopsy-adjacent decision support, although it does not yet replace histopathological assessment.
Methods
This review systematically evaluates the predictive performance of CT-based radiomics in characterizing solid renal tumors. A literature search was conducted in PubMed/MEDLINE, Cochrane, and Scopus databases for original research published between 2012 and 2025. The review focuses on four key areas: differentiating benign renal tumors from RCC, clear cell (ccRCC) from non-ccRCC, fpAML from RCC, and RO from RCC.
Results
In total, 47 studies were assessed, including 11,999 patients. CT-based radiomics demonstrates high diagnostic performance across all categories. Median Area Under the Curve values were 0.830 (0.747–0.900) for benign vs. malignant differentiation, 0.900 (0.861–0.910) for ccRCC vs. non-ccRCC, 0.912 (0.879–0.933) for fpAML vs. RCC, and 0.885 (0.841–0.947) for RO vs. RCC. The integration of radiomic features with clinical parameters into combined nomograms consistently yielded the highest predictive accuracy.
Conclusions
Radiomics provides a non-invasive, objective method to characterize renal tumors, potentially reducing unnecessary surgeries and enabling personalized treatment. However, widespread clinical adoption remains limited by a lack of protocol standardization, the need for automated segmentation, and the requirement for prospective, multicenter validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Radiology, University Hospital of Ioannina, University Campus, 45110 Ioannina, Greece.
- Department of Neurosurgery, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, 45110 Ioannina, Greece.
- Department of Clinical Radiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, 45110 Ioannina, Greece.
ORCID-Profile: Petros Koumpis, Eleni Romeo, George A Alexiou, Maria I Argyropoulou
Zitieren
APA
Koumpis, P., Vartholomatos, E., Romeo, E., Alexiou, G. A., Argyropoulou, M. I., & Tsili, A. C. (2026). CT-Based Radiomics in the Characterization of Solid Renal Tumors: A Systematic Review. Cancers, 18(11), 1758. https://doi.org/10.3390/cancers18111758
Vancouver
Koumpis P, Vartholomatos E, Romeo E, Alexiou GA, Argyropoulou MI, Tsili AC. CT-Based Radiomics in the Characterization of Solid Renal Tumors: A Systematic Review. Cancers. 2026;18(11):1758. doi:10.3390/cancers18111758
BibTeX
@article{Koumpis2026,
author = {Koumpis, Petros and Vartholomatos, Eyrysthenis and Romeo, Eleni and Alexiou, George A and Argyropoulou, Maria I and Tsili, Athina C},
title = {CT-Based Radiomics in the Characterization of Solid Renal Tumors: A Systematic Review},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1758},
doi = {10.3390/cancers18111758}
}
EUVIMED